|Bank of America||Michael Cherny|
|Credit Suisse||Judah Frommer|
|LifeSci Capital||Rahul Rakhit|
|TD Cowen||Charles Rhyee|
Pear Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Pear Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Pear Therapeutics, Inc. or its management. Pear Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.